Integrating geriatric expertise into multidisciplinary tumour boards offers a viable model for managing older adults with colorectal cancer, according to a pragmatic real-world cohort study published in the Journal of Geriatric Oncology (JGO). Researchers found that selective referrals driven by an onco-geriatrician participating directly in tumour board discussions yielded patient outcomes comparable to those managed without comprehensive geriatric assessment (CGA), despite managing older populations with higher baseline frailty and comorbidity.
Evaluating Geriatric Expertise in Multidisciplinary Tumour Boards
The study, led by Annaelle Doyen and a team of researchers including Olivier S. Descamps, Thibaud De Blauwe, and Sophie Bettens, evaluated 170 patients aged 70 and older diagnosed with colorectal cancer. Investigators compared patient outcomes in a clinical model where an onco-geriatrician joined every multidisciplinary tumour board and selectively referred patients for comprehensive geriatric assessments against a management approach without it. According to the findings published by the International Society of Geriatric Oncology (SIOG), the cohort undergoing the CGA presented with greater baseline frailty and higher comorbidity rates. Despite these risk factors, the two groups experienced similar rates of major complications, severe toxicity, treatment interruptions, and 90-day mortality.
Did you know? The International Society of Geriatric Oncology (SIOG) provides free online access to the Journal of Geriatric Oncology for its members, supporting ongoing research dissemination in cancer care for older adults.
Scaling Geriatric Oncology Resources in Clinical Practice
As cancer incidence rises among aging populations, healthcare systems frequently face shortages of dedicated geriatric oncology resources. The authors of the JGO study suggest that embedding geriatric expertise directly into tumour board discussions establishes a scalable model where dedicated geriatric oncology resources are limited. This selective referral mechanism ensures that vulnerable older adults receive targeted evaluations without overwhelming specialized clinical capacity.
Previous consensus recommendations from organizations such as SIOG have long emphasized the utility of screening tools for multidimensional health problems in older cancer patients, as outlined in guidelines published by researchers including Hans Wildiers and Martine Extermann in journals like the Journal of Clinical Oncology and Annals of Oncology.
Frequently Asked Questions
What is a comprehensive geriatric assessment (CGA) in cancer care?
A comprehensive geriatric assessment is a multidimensional diagnostic process used to determine an older adult’s medical, psychosocial, and functional capability, helping oncology teams tailor cancer treatments safely.
How does embedding an onco-geriatrician on a tumour board help older patients?
According to the JGO study, having an onco-geriatrician participate in multidisciplinary tumour boards allows for targeted referrals and integrated care planning, achieving patient safety outcomes comparable to those managed without CGA even among frailer populations.
Who authored the recent JGO study on colorectal cancer care?
The study was authored by Annaelle Doyen, Olivier S. Descamps, Thibaud De Blauwe, Pierre Stangherlin, Caterina Confente, Pauline Baudouin, Aurore Decleve, Alexandre Nisolle, Nathalie Denewet, Sandra Higuet, and Sophie Bettens.
Join the Conversation
How is your institution integrating geriatric assessments into oncology workflows? Share your thoughts or clinical experiences in the comments below, and subscribe to our newsletter for the latest updates in oncology research.
Worth a look